You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,796,741


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,796,741
Title:Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Abstract:Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein Ror Ron the A group is an aryl, heteroaryl or heterocycle (R) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
Inventor(s):Gadhachanda Venkat Rao, Wang Qiuping, Pais Godwin, Hashimoto Akihiro, Chen Dawei, Wang Xiangzhu, Agarwal Atul, Deshpande Milind, Wiles Jason Allan, Phadke Avinash S.
Assignee:Achillion Pharmaceuticals, Inc.
Application Number:US14631625
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,796,741: A Comprehensive Analysis

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, especially for businesses and inventors looking to protect or utilize innovative technologies. This article will delve into the details of United States Patent 9,796,741, exploring its scope, claims, and the broader patent landscape it operates within.

What is United States Patent 9,796,741?

To begin with, it is essential to identify the subject matter of the patent. However, since the specific details of Patent 9,796,741 are not provided in the sources, we will use general principles of patent analysis to guide our discussion.

Patent Search and Retrieval

The first step in analyzing a patent is to retrieve the patent document. This can be done through the U.S. Patent and Trademark Office (USPTO) public search facilities or online databases such as the USPTO's Patent Full-Text and Image Database (PatFT)[4].

Understanding Patent Claims

Patent claims are the heart of any patent, as they define the scope of protection granted to the inventor. Claims are typically categorized into independent and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are crucial because they set the broadest scope of protection for the invention.

Dependent Claims

Dependent claims, on the other hand, refer back to and further limit the scope of an independent claim. They often add specific details or features to the invention described in the independent claim.

Analyzing the Specification

The specification section of the patent provides a detailed description of the invention, including drawings and diagrams. This section is essential for understanding how the invention works and what it encompasses.

Prior Art and Patentability

Prior art refers to the existing body of knowledge in the field of the invention. When analyzing a patent, it is crucial to consider the prior art cited during the patent prosecution process to understand how the invention differs from what was already known.

Patent Term and Adjustments

Patents have a limited term, typically 20 years from the filing date of the earliest non-provisional application. However, delays during the prosecution process can result in Patent Term Adjustments (PTA) to compensate for the time lost. The case of In re Cellect highlights the complexities surrounding PTA and obviousness-type double patenting (ODP)[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This is particularly relevant when multiple patents from the same family have different expiration dates due to PTA or other adjustments[1].

Patent Family and Continuations

Patents can be part of a larger family, including continuations, continuations-in-part, and divisional applications. Understanding the relationships between these patents is vital for a comprehensive analysis. For example, in In re Cellect, the patents were interrelated, with some being continuations-in-part of earlier patents[1].

Economic and Legal Implications

The economic and legal implications of a patent are significant. Patents can provide a competitive edge, but they also come with legal obligations and potential challenges. The USPTO's economic research datasets can provide insights into the economic impact of patents and their scope[3].

Global Dossier and International Considerations

In today's globalized world, patents often have international implications. Tools like the Global Dossier allow users to access file histories of related applications from participating IP Offices, facilitating a more integrated global patent system[4].

Public Search Facilities and Resources

The USPTO offers various resources for patent search and analysis, including the Public Search Facility in Alexandria, VA, and Patent and Trademark Resource Centers (PTRCs) across the country. These resources can be invaluable for conducting thorough patent searches and analyses[4].

Small Claims Patent Court Considerations

For smaller inventors or businesses, the concept of a small claims patent court is being explored. This could potentially simplify and reduce the costs associated with patent litigation, making it more accessible to a broader range of stakeholders[5].

Key Takeaways

  • Patent Claims: The claims section is critical for defining the scope of protection.
  • Prior Art: Understanding prior art is essential for determining patentability.
  • Patent Term Adjustments: Delays in prosecution can lead to PTA, affecting the patent term.
  • ODP: Prevents securing a second, later-expiring patent for an invention not patentably distinct from an earlier patent.
  • Patent Family: Understanding the relationships between related patents is vital.
  • Global Considerations: Patents have international implications, and tools like the Global Dossier can facilitate global patent management.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines the scope of protection granted to the inventor, distinguishing the invention from prior art.

How do Patent Term Adjustments (PTA) affect a patent?

PTA compensate for delays during the prosecution process, extending the patent term beyond the standard 20 years from the filing date.

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent.

How can I access detailed information about a patent?

You can access detailed information through the USPTO's public search facilities or online databases like PatFT.

What resources are available for conducting patent searches?

Resources include the USPTO Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and online tools like the Global Dossier.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,796,741

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alexion Pharms Inc VOYDEYA danicopan TABLET;ORAL 218037-001 Mar 29, 2024 RX Yes No ⤷  Subscribe ⤷  Subscribe Y TREATMENT OF EXTRAVASCULAR HEMOLYSIS (EVH) IN ADULTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AS ADD-ON THERAPY TO RAVULIZUMAB OR ECULIZUMAB ⤷  Subscribe
Alexion Pharms Inc VOYDEYA danicopan TABLET;ORAL 218037-002 Mar 29, 2024 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y TREATMENT OF EXTRAVASCULAR HEMOLYSIS (EVH) IN ADULTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AS ADD-ON THERAPY TO RAVULIZUMAB OR ECULIZUMAB ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,796,741

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015223068 ⤷  Subscribe
Australia 2015223072 ⤷  Subscribe
Australia 2015223075 ⤷  Subscribe
Australia 2015223084 ⤷  Subscribe
Australia 2015223121 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.